ArticleNuclear medicine and biology2016

Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R).

David S Geller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.